Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status: An Updated Systematic Review and Meta-analysis
- PMID: 35482308
- PMCID: PMC9051991
- DOI: 10.1001/jamanetworkopen.2022.9317
Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status: An Updated Systematic Review and Meta-analysis
Abstract
Importance: An overall household secondary attack rate (SAR) of 18.9% (95% CI, 16.2%-22.0%) through June 17, 2021 was previously reported for SARS-CoV-2. Emerging variants of concern and increased vaccination have affected transmission rates.
Objective: To evaluate how reported household SARs changed over time and whether SARs varied by viral variant and index case and contact vaccination status.
Data sources: PubMed and medRxiv from June 18, 2021, through March 8, 2022, and reference lists of eligible articles. Preprints were included.
Study selection: Articles with original data reporting the number of infected and total number of household contacts. Search terms included SARS-CoV-2, COVID-19, variant, vaccination, secondary attack rate, secondary infection rate, household, index case, family contacts, close contacts, and family transmission.
Data extraction and synthesis: The Preferred Reporting Items for Systematic Reviews and Meta-Analyses reporting guideline was followed. Meta-analyses used generalized linear mixed models to obtain SAR estimates and 95% CIs.
Main outcomes and measures: SAR stratified by covariates according to variant, index case and contact vaccination status, and index case identification period. SARs were used to estimate vaccine effectiveness on the basis of the transmission probability for susceptibility to infection (VES,p), infectiousness given infection (VEI,p), and total vaccine effectiveness (VET,p).
Results: Household SARs were higher for 33 studies with midpoints in 2021 to 2022 (37.3%; 95% CI, 32.7% to 42.1%) compared with 63 studies with midpoints through April 2020 (15.5%; 95% CI, 13.2% to 18.2%). Household SARs were 42.7% (95% CI, 35.4% to 50.4%) for Omicron (7 studies), 36.4% (95% CI, 33.4% to 39.5%) for Alpha (11 studies), 29.7% (95% CI, 23.0% to 37.3%) for Delta (16 studies), and 22.5% (95% CI, 18.6% to 26.8%) for Beta (3 studies). For full vaccination, VES,p was 78.6% (95% CI, 76.0% to 80.9%) for Alpha, 56.4% (95% CI, 54.6% to 58.1%) for Delta, and 18.1% (95% CI, -18.3% to 43.3%) for Omicron; VEI,p was 75.3% (95% CI, 69.9% to 79.8%) for Alpha, 21.9% (95% CI, 11.0% to 31.5%) for Delta, and 18.2% (95% CI, 0.6% to 32.6%) for Omicron; and VET,p was 94.7% (95% CI, 93.3% to 95.8%) for Alpha, 64.4% (95% CI, 58.0% to 69.8%) for Delta, and 35.8% (95% CI, 13.0% to 52.6%) for Omicron.
Conclusions and relevance: These results suggest that emerging SARS-CoV-2 variants of concern have increased transmissibility. Full vaccination was associated with reductions in susceptibility and infectiousness, but more so for Alpha than Delta and Omicron. The changes in estimated vaccine effectiveness underscore the challenges of developing effective vaccines concomitant with viral evolution.
Conflict of interest statement
Figures




Update of
-
Household secondary attack rates of SARS-CoV-2 by variant and vaccination status: an updated systematic review and meta-analysis.medRxiv [Preprint]. 2022 Jan 11:2022.01.09.22268984. doi: 10.1101/2022.01.09.22268984. medRxiv. 2022. Update in: JAMA Netw Open. 2022 Apr 1;5(4):e229317. doi: 10.1001/jamanetworkopen.2022.9317. PMID: 35043125 Free PMC article. Updated. Preprint.
Similar articles
-
Factors Associated With Household Transmission of SARS-CoV-2: An Updated Systematic Review and Meta-analysis.JAMA Netw Open. 2021 Aug 2;4(8):e2122240. doi: 10.1001/jamanetworkopen.2021.22240. JAMA Netw Open. 2021. PMID: 34448865 Free PMC article.
-
Household secondary attack rates of SARS-CoV-2 by variant and vaccination status: an updated systematic review and meta-analysis.medRxiv [Preprint]. 2022 Jan 11:2022.01.09.22268984. doi: 10.1101/2022.01.09.22268984. medRxiv. 2022. Update in: JAMA Netw Open. 2022 Apr 1;5(4):e229317. doi: 10.1001/jamanetworkopen.2022.9317. PMID: 35043125 Free PMC article. Updated. Preprint.
-
Household Transmission of SARS-CoV-2: A Systematic Review and Meta-analysis.JAMA Netw Open. 2020 Dec 1;3(12):e2031756. doi: 10.1001/jamanetworkopen.2020.31756. JAMA Netw Open. 2020. PMID: 33315116 Free PMC article.
-
Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021-2022.Vaccine. 2023 May 11;41(20):3292-3300. doi: 10.1016/j.vaccine.2023.03.069. Epub 2023 Apr 5. Vaccine. 2023. PMID: 37085456 Free PMC article.
-
Susceptibility and infectiousness of SARS-CoV-2 in children versus adults, by variant (wild-type, alpha, delta): A systematic review and meta-analysis of household contact studies.PLoS One. 2024 Sep 6;19(9):e0306740. doi: 10.1371/journal.pone.0306740. eCollection 2024. PLoS One. 2024. PMID: 39240908 Free PMC article.
Cited by
-
COVID-19 in Older Adults at the Time of the Omicron Variant.J Clin Med. 2022 Sep 7;11(18):5273. doi: 10.3390/jcm11185273. J Clin Med. 2022. PMID: 36142920 Free PMC article.
-
Impact of Vaccination With the SCB-2019 Coronavirus Disease 2019 Vaccine on Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Household Contact Study in the Philippines.Clin Infect Dis. 2023 Apr 3;76(7):1180-1187. doi: 10.1093/cid/ciac914. Clin Infect Dis. 2023. PMID: 36433685 Free PMC article.
-
Comprehensive profiling of the human viral exposome in households containing an at-risk child with mitochondrial disease during the 2020-2021 COVID-19 pandemic.Clin Transl Med. 2022 Nov;12(11):e1100. doi: 10.1002/ctm2.1100. Clin Transl Med. 2022. PMID: 36336785 Free PMC article.
-
Can high COVID-19 vaccination rates in adults help protect unvaccinated children? Evidence from a unique mass vaccination campaign, Schwaz/Austria, March 2021.Euro Surveill. 2022 Sep;27(39):2101027. doi: 10.2807/1560-7917.ES.2022.27.39.2101027. Euro Surveill. 2022. PMID: 36177866 Free PMC article.
-
Nosocomial transmission of SARS-CoV-2 from infected children to uninfected caregivers: A retrospective cohort study in a Japanese tertiary children's hospital.J Infect Chemother. 2023 Mar;29(3):281-283. doi: 10.1016/j.jiac.2022.11.013. Epub 2022 Dec 5. J Infect Chemother. 2023. PMID: 36470374 Free PMC article.
References
-
- Klaassen F, Chitwood MH, Cohen T, et al. . Population immunity to pre-Omicron and Omicron SARS-CoV-2 variants in US states and counties through December 1, 2021. medRxiv. Preprint posted online March 1, 2022.
-
- Halloran ME, Longini IM, Struchiner CJ, Longini IM. Design and Analysis of Vaccine Studies. Vol 18. Springer; 2010. doi:10.1007/978-0-387-68636-3 - DOI
-
- Halloran ME, Préziosi MP, Chu H. Estimating vaccine efficacy from secondary attack rates. J Am Stat Assoc. 2003;98(461):38-46. doi:10.1198/016214503388619076 - DOI
Publication types
MeSH terms
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous